ETF overview
The Global X Genomics & Biotechnology ETF, known by its ticker GNOM, aims to closely track the performance of the Solactive Genomics Index, reflecting both its price appreciation and any generated income. This mirroring occurs before the deduction of the ETF's internal fees and expenses.
Fund facts
- Expense ratio
- 0.50%
- Fund assets
- 108.4M USD (all share classes)
- Issuer
- Global X
- Inception date
- Apr 5, 2019
- Number of holdings
- 50
Breakdown
Holdings (50)
| Name | Ticker | Weight |
|---|---|---|
| MODERNA INC | MRNA | 11.05% |
| TWIST BIOSCIENCE CORP | TWST | 6.70% |
| 10X GENOMICS INC-CLASS A | TXG | 6.38% |
| ILLUMINA INC | ILMN | 6.09% |
| NATERA INC | NTRA | 5.50% |
| GUARDANT HEALTH INC | GH | 5.22% |
| GENSCRIPT BIOTECH CORP | 1548.HK | 4.58% |
| BIO-TECHNE CORP | TECH | 3.56% |
| VERTEX PHARMACEUTICALS INC | VRTX | 3.33% |
| QIAGEN N.V. | QGEN | 3.26% |
| and 37 more | ||
Similar ETFs
- Global X - Genomics & Biotechnology UCITS ETFGNOG.L · Overlap 97% · Expense ratio 0.50%
- ARK Genomic Revolution ETFARKG · Overlap 42% · Expense ratio 0.75%
- Ark Genomic Revolution Ucits ETF AccumUSDARKG.L · Overlap 42% · Expense ratio 0.75%
- Invesco Biotechnology & Genome ETFPBE · Overlap 32% · Expense ratio 0.59%
Overlap is the share of assets the two funds hold in common.
Historical returns do not guarantee future returns. This is not investment advice.
- Expense ratio
- 0.50%
- Fund assets
- 108.4M USD (all share classes)
- Issuer
- Global X
- Inception date
- Apr 5, 2019
- Number of holdings
- 50
| Name | Ticker | Weight |
|---|---|---|
| MODERNA INC | MRNA | 11.05% |
| TWIST BIOSCIENCE CORP | TWST | 6.70% |
| 10X GENOMICS INC-CLASS A | TXG | 6.38% |
| ILLUMINA INC | ILMN | 6.09% |
| NATERA INC | NTRA | 5.50% |
| GUARDANT HEALTH INC | GH | 5.22% |
| GENSCRIPT BIOTECH CORP | 1548.HK | 4.58% |
| BIO-TECHNE CORP | TECH | 3.56% |
| VERTEX PHARMACEUTICALS INC | VRTX | 3.33% |
| QIAGEN N.V. | QGEN | 3.26% |
| and 37 more | ||
The Global X Genomics & Biotechnology ETF, known by its ticker GNOM, aims to closely track the performance of the Solactive Genomics Index, reflecting both its price appreciation and any generated income. This mirroring occurs before the deduction of the ETF's internal fees and expenses.
- Global X - Genomics & Biotechnology UCITS ETFGNOG.L · Overlap 97% · Expense ratio 0.50%
- ARK Genomic Revolution ETFARKG · Overlap 42% · Expense ratio 0.75%
- Ark Genomic Revolution Ucits ETF AccumUSDARKG.L · Overlap 42% · Expense ratio 0.75%
- Invesco Biotechnology & Genome ETFPBE · Overlap 32% · Expense ratio 0.59%
Overlap is the share of assets the two funds hold in common.
Unlock all ETF data
Sign up for FreeUnlock all ETF data
Sign up for Free